average weight loss glp-1 drugs GLP-1R Agonists for GLP-1 receptor gene variant boosts

What Else is New with GLP-1s While much of the news about health insurance coverage for GLP-1s is bad, there's good news too

In one reported case, it was difficult for the patient to obtain clarity on dosing instructions from the telemedicine provider, who prescribed the compounded semaglutide, leading the patient to conduct an online search for medical advice and resulting in the patient taking five times the intended dose

The American Diabetes Association (ADA) guidelines updated in 2023 recommend GLP-1 receptor agonists as a preferred treatment option for many patients with type 2 diabetes, particularly those with or at high risk for cardiovascular disease or kidney disease

Pharmacol Res 182(June):106320

Semaglutide attenuates seizure severity and ameliorates cognitive dysfunction by blocking the NLR family pyrin domain containing 3 inflammasome in pentylenetetrazole-kindled mice

Comment on: the effect of semaglutide and GLP-1 RAs on risk of nonarteritic anterior ischemic optic neuropathy [published online ahead of print June 20, 2025]